Prospective Evaluation of the First Option, Second-Line Therapy in Childhood Chronic Immune Thrombocytopenia: Splenectomy or Immunomodulation.
J Pediatr
; 231: 223-230, 2021 04.
Article
in En
| MEDLINE
| ID: mdl-33340549
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Splenectomy
/
Azathioprine
/
Purpura, Thrombocytopenic, Idiopathic
/
Immunomodulation
/
Rituximab
/
Hydroxychloroquine
Type of study:
Observational_studies
/
Risk_factors_studies
Limits:
Adolescent
/
Child
/
Child, preschool
/
Female
/
Humans
/
Infant
/
Male
Language:
En
Journal:
J Pediatr
Year:
2021
Document type:
Article
Affiliation country:
Francia